SCHEMBL31039733

SCHEMBL31039733

COC(CNC(=O)CCN1CCC[C@@H](Nc2nnc(Cl)c(C)n2)C1)OC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 8/20 0.41
KAT2B Q92831 2/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CDK2 P24941 2/20 0.33
CCNT1 O60563 1/20 0.33
CCNK O75909 1/20 0.33
CCNE1 P24864 1/20 0.33
CDK7 P50613 1/20 0.33
CDK9 P50750 1/20 0.33
CCNH P51946 1/20 0.33
MNAT1 P51948 1/20 0.33
CDK12 Q9NYV4 1/20 0.33
KMT2A Q03164 2/20 0.33
TERT O14746 1/20 0.33
JUN P05412 2/20 0.33
MAPK8 P45983 2/20 0.33
MAPK9 P45984 2/20 0.33
MAPK10 P53779 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31039735 0.79 KAT2B (0.53) NLRP3KAT2BCDK2CCNT1CCNK
SCHEMBL27292457 0.79 NLRP3 (0.55) NLRP3KAT2BCDK2CCNT1CCNK
SCHEMBL31341807 0.78 ROCK2 (0.45) NLRP3KAT2B
SCHEMBL31039746 0.78 NLRP3 (0.43) NLRP3KAT2B
SCHEMBL31039740 0.78 NLRP3 (0.44) NLRP3KAT2BCDK2CCNT1CCNK
SCHEMBL31039762 0.77 NLRP3 (0.56) NLRP3KAT2BCDK2CCNT1CCNK
SCHEMBL24695702 0.76 CAMK2D (0.45) NLRP3KAT2B
SCHEMBL29159546 0.76 CAMK2D (0.45) NLRP3KAT2B
SCHEMBL31166567 0.74 NLRP3 (0.57) NLRP3KAT2BALDH1A1KMT2ATERT
SCHEMBL31341805 0.72 NLRP3 (0.40) NLRP3KAT2BCDK2CCNKCDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630417-A1 NOVEL COMPOUNDS AS MODULATORS OF NLRP3 INHIBITION F. Hoffmann-La Roche AG (CH) 2025-10-15 EP disclosed
WO-2024121086-A1 NOVEL COMPOUNDS AS MODULATORS OF NLRP3 INHIBITION F. HOFFMANN-LA ROCHE AG (CH) 2024-06-13 WO disclosed